Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prithviraj Bose

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Expert Review of Hematology|November 14, 2012
Complementary combinations: what treatments will become key to the battle against acute myelogenous leukemia?Prithviraj Bose, Steven Grant
Blood|December 9, 2017
T-PLL: another check on the venetoclax list?Prithviraj Bose, Marina Y Konopleva
Leukemia & Lymphoma|November 15, 2021
Novel strategies for challenging scenarios encountered in managing myelofibrosisPrithviraj Bose, Ruben A Mesa
Cancer Cell|March 14, 2018
ORY-1001: Overcoming the Differentiation Block in AMLPrithviraj Bose, Marina Y Konopleva
Expert Opinion on Pharmacotherapy|July 27, 2024
Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literatureAnthony M Hunter, Prithviraj Bose
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2024
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic MastocytosisHelen T Chifotides, Prithviraj Bose
Cancers|October 14, 2020
Novel Concepts of Treatment for Patients with Myelofibrosis and Related NeoplasmsPrithviraj Bose, Lucia Masarova, Srdan Verstovsek
Pharmacology & Therapeutics|April 29, 2014
Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insightsPrithviraj Bose, Yun Dai, Steven Grant
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
Novel treatment strategies for myeloproliferative neoplasmsPrithviraj Bose, Lucia Masarova, Srdan Verstovsek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
Disease Modification in Myelofibrosis: An Elusive Goal?Pankit Vachhani, Srdan Verstovsek, Prithviraj Bose
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Expert Review of Hematology|November 14, 2012
Complementary combinations: what treatments will become key to the battle against acute myelogenous leukemia?Prithviraj Bose, Steven Grant
Blood|December 9, 2017
T-PLL: another check on the venetoclax list?Prithviraj Bose, Marina Y Konopleva
Leukemia & Lymphoma|November 15, 2021
Novel strategies for challenging scenarios encountered in managing myelofibrosisPrithviraj Bose, Ruben A Mesa
Cancer Cell|March 14, 2018
ORY-1001: Overcoming the Differentiation Block in AMLPrithviraj Bose, Marina Y Konopleva
Expert Opinion on Pharmacotherapy|July 27, 2024
Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literatureAnthony M Hunter, Prithviraj Bose
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2024
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic MastocytosisHelen T Chifotides, Prithviraj Bose
Cancers|October 14, 2020
Novel Concepts of Treatment for Patients with Myelofibrosis and Related NeoplasmsPrithviraj Bose, Lucia Masarova, Srdan Verstovsek
Pharmacology & Therapeutics|April 29, 2014
Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insightsPrithviraj Bose, Yun Dai, Steven Grant
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
Novel treatment strategies for myeloproliferative neoplasmsPrithviraj Bose, Lucia Masarova, Srdan Verstovsek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
Disease Modification in Myelofibrosis: An Elusive Goal?Pankit Vachhani, Srdan Verstovsek, Prithviraj Bose
Pageof 23